Lv2
180 积分 2025-07-21 加入
Elevated Lipoprotein(a) prevalence and association with family history of premature cardiovascular disease in general population with moderate cardiovascular risk and increased LDL cholesterol
19天前
已关闭
Association between elevated lipoprotein(a) levels and vulnerability of carotid atherosclerotic plaque: A systematic review
1个月前
已完结
Lipoprotein(a) associates with high-resolution MRI-assessed intracranial plaque vulnerability and long-term stroke recurrence
1个月前
已完结
Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia
2个月前
已完结
Optimizing PCSK9 inhibitor therapy: Understanding and managing suboptimal LDL-C response in clinical practice
2个月前
已完结
Effect of evolocumab on carotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) using magnetic resonance imaging
3个月前
已完结
Inhibition of PCSK9 Protects against Cerebral Ischemia‒Reperfusion Injury via Attenuating Microcirculatory Dysfunction
3个月前
已完结
Efficacy and safety of PCSK9 inhibitors for stroke prevention: Systematic review and meta-analysis
3个月前
已完结
Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid‐Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis
3个月前
已完结
Effect of Lipid-lowering Therapies on Lipoprotein(a) Levels: A Comprehensive Meta-analysis of Randomized Controlled Trials
3个月前
已完结
皖公网安备34019202002308
